HL
Harding Loevner’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-1,791,651
| Closed | -$103M | – | 107 |
|
2015
Q4 | $103M | Sell |
1,791,651
-1,067,662
| -37% | -$61.5M | 0.84% | 48 |
|
2015
Q3 | $155M | Buy |
2,859,313
+91,810
| +3% | +$4.98M | 1.25% | 33 |
|
2015
Q2 | $152M | Buy |
2,767,503
+166,270
| +6% | +$9.11M | 1.06% | 39 |
|
2015
Q1 | $139M | Buy |
2,601,233
+196,936
| +8% | +$10.5M | 1.06% | 38 |
|
2014
Q4 | $102M | Buy |
2,404,297
+4,206
| +0.2% | +$178K | 0.82% | 49 |
|
2014
Q3 | $115M | Buy |
2,400,091
+378,455
| +19% | +$18.1M | 0.85% | 49 |
|
2014
Q2 | $93.4M | Buy |
2,021,636
+12,266
| +0.6% | +$567K | 0.7% | 51 |
|
2014
Q1 | $91.7M | Buy |
2,009,370
+1,713,243
| +579% | +$78.2M | 0.7% | 49 |
|
2013
Q4 | $54.7M | Buy |
296,127
+80,386
| +37% | +$14.9M | 0.42% | 59 |
|
2013
Q3 | $36.3M | Sell |
215,741
-50,613
| -19% | -$8.53M | 0.32% | 63 |
|
2013
Q2 | $42.8M | Buy |
+266,354
| New | +$42.8M | 0.41% | 59 |
|